Table 3.
Grade 3–4 adverse events (CTCAE version 3.0, Concurrent chemoradiotherapy course N = 15, Consolidation chemotherapy course N = 14)
| Toxicity grade 3–4 | Concurrent chemoradiotherapy N (%) | Consolidation chemotherapy N (%) |
|---|---|---|
| Neutropenia | 5 (33.3) | 2 (14.3) |
| Anemia | 2 (13.3) | 3 (21.4) |
| Thrombocytopenia | 2 (13.3) | 1 (7.1) |
| Febrile neutropenia | 1 (6.7) | 0 (0.0) |
| Vomiting | 2 (13.3) | 0 (0.0) |
| Esophagitis | 3 (20.0) | 1 (7.1) |
| Transaminase | 1 (6.7) | 0 (0.0) |
| Pneumonitis | 1 (6.7) | 0 (0.0) |
| Creatinine | 0 | 0 (0.0) |